JAMA Network Home
Sign In
Comment & Response

Reassessing Treatment Outcomes Following Immune-Related Adverse Events—Reply

JAMA Oncology 10.1001/jamaoncol.2026.0785

April 23, 2026 at 11:00 AM EDT

Read the full article

Corresponding Author: Joseph M. Unger, PhD, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M3-C102, PO Box 19024, Seattle, WA 98109-1024 (junger@fredhutch.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2026.0785?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=042326

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks